Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Forced-Air Warming for Preventing Perioperative Hypothermia During Total Knee Arthroplasty

21 mai 2026 mis à jour par: DanLing Fang, Shanghai 6th People's Hospital

Effect of Intraoperative Forced-air Warming on Perioperative Hypothermia and Related Complications in Patients Undergoing Total Knee Arthroplasty: A Historical Control Study

Perioperative hypothermia is a common complication during total knee arthroplasty (TKA) and may increase the risk of shivering, delayed anesthetic recovery, and postoperative complications. This historical control study aims to evaluate the effectiveness and safety of intraoperative forced-air warming in preventing perioperative hypothermia in patients undergoing primary unilateral TKA.

A total of 240 patients were included. Patients in the historical control group received routine passive warming measures, while patients in the intervention group received additional forced-air warming during the perioperative period. Core body temperature, incidence of inadvertent perioperative hypothermia, anesthetic recovery outcomes, postoperative complications, and safety outcomes were evaluated.

Aperçu de l'étude

Description détaillée

This single-center historical control study was conducted at Shanghai 6th People's Hospital between May 2018 and December 2018 to evaluate the effectiveness of intraoperative forced-air warming for preventing perioperative hypothermia in patients undergoing total knee arthroplasty (TKA).

A total of 240 patients undergoing primary unilateral TKA were enrolled and divided into two groups according to the study period. Patients enrolled between May 2018 and August 2018 were assigned to the historical control group and received routine passive warming measures, including warmed intravenous fluids, warmed irrigation fluids, operating room temperature control, and cotton blanket coverage. Patients enrolled between September 2018 and December 2018 were assigned to the intervention group and received additional active warming using a forced-air warming system during the perioperative period.

The forced-air warming system was initiated 30 minutes before anesthesia induction and continued until transfer to the post-anesthesia care unit (PACU). Core temperature was continuously monitored using a temperature-sensing urinary catheter.

The primary outcomes included perioperative core temperature changes and the incidence of inadvertent perioperative hypothermia, defined as core temperature below 36°C at any perioperative time point. Secondary outcomes included postoperative shivering, emergence agitation, anesthetic recovery time, blood loss, postoperative complications, and safety outcomes including skin burns and surgical site infection.

This study was approved by the Ethics Committee of Shanghai 6th People's Hospital (Approval No. 05.12.19035). Written informed consent was obtained from all participants before enrollment.

Type d'étude

Interventionnel

Inscription (Réel)

240

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Chine, 200233
        • Shanghai 6th People's Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Age between 60 and 85 years
  • ASA physical status I or II
  • Diagnosed with knee osteoarthritis
  • Undergoing first unilateral primary total knee arthroplasty
  • Able to provide written informed consent

Exclusion Criteria:

  • Abnormal coagulation function (international normalized ratio >1.2)
  • Preoperative body temperature >37.5°C or <36°C
  • Cognitive or psychiatric disorders affecting communication
  • Moderate or severe anemia
  • Body mass index >30 kg/m² or <18.5 kg/m²
  • Moderate or severe malnutrition
  • Surgery duration longer than 4 hours
  • Intraoperative blood loss greater than 500 mL
  • Transfer to surgical intensive care unit after surgery

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Non randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Forced-Air Warming Group
Participants received routine passive warming measures plus active warming using a forced-air warming system during the perioperative period.
Active perioperative warming using a forced-air warming system initiated 30 minutes before anesthesia induction and continued until transfer to the post-anesthesia care unit.
Comparateur actif: Routine Warming Group
Participants received routine passive warming measures including warmed fluids, operating room temperature control, and cotton blanket coverage.
Routine perioperative warming measures including warmed intravenous fluids, warmed irrigation fluids, operating room temperature control, and cotton blanket coverage.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Incidence of Inadvertent Perioperative Hypothermia
Délai: From anesthesia induction to 90 minutes after anesthesia completion
The proportion of participants with core body temperature below 36.0°C at any perioperative time point.
From anesthesia induction to 90 minutes after anesthesia completion
Perioperative Core Temperature Change
Délai: From operating room entry to 90 minutes after anesthesia completion
Core body temperature measured using a temperature-sensing urinary catheter at predefined perioperative time points.
From operating room entry to 90 minutes after anesthesia completion

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Postoperative Shivering
Délai: From the end of surgery to 24 hours postoperatively
Incidence and severity of postoperative shivering assessed using a 0-4 shivering scale.
From the end of surgery to 24 hours postoperatively
Emergence Agitation
Délai: From 30 minutes after surgery to 2 hours postoperatively
Incidence and severity of emergence agitation assessed using the Richmond Agitation-Sedation Scale (RASS, -5 to +4), where higher positive scores indicate greater agitation.
From 30 minutes after surgery to 2 hours postoperatively
Anesthetic Recovery Time
Délai: From the end of anesthesia to 2 hours postoperatively
Recovery outcomes including awakening time, extubation time, and PACU length of stay.
From the end of anesthesia to 2 hours postoperatively
Intraoperative Blood Loss
Délai: During surgery
Estimated blood loss recorded during the surgical procedure.
During surgery
Postoperative Complications
Délai: From the end of surgery to 30 days postoperatively
Incidence of postoperative complications including delirium, nausea and vomiting, cardiac adverse events, skin burns, and surgical site infection.
From the end of surgery to 30 days postoperatively

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Danling Fang, RN, Shanghai 6th People's Hospital

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 mai 2018

Achèvement primaire (Réel)

31 décembre 2018

Achèvement de l'étude (Réel)

31 janvier 2019

Dates d'inscription aux études

Première soumission

13 mai 2026

Première soumission répondant aux critères de contrôle qualité

21 mai 2026

Première publication (Réel)

29 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

29 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

21 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be publicly shared because the study involves retrospective clinical data and institutional privacy restrictions.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Arthroplastie totale du genou

Essais cliniques sur Forced-Air Warming

S'abonner